Panbela Therapeutics

Price & Volume

Stats

52W Range	$0.30-$38
Market Cap	$1.6M
Shares Short	106,974

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$34.51

News

Yahoo Finance • 12 months ago

Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification

Yahoo Finance • last year

Panbela Provides Business Update and Reports Q3 2023 Financial Results

Yahoo Finance • last year

Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds Priced At-the-Market

Yahoo Finance • last year

Panbela Announces Publication of Preclinical and Clinical Data Titled: Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 Diabetes

About

CEO	Dr. Jennifer K. Simpson CRNP, M.S.N., Ph.D.
CFO	Ms. Susan Horvath
Address	712 Vista Boulevard, Waconia, MN, United States, 55387
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	7